Potential reduction in healthcare carbon footprint by autonomous artificial intelligence. - Risa M. Wolf; Michael D. Abràmoff; Roomasa Channa; Chris Tava; Warren Clarida; Harold P. Lehmann (npj Digit. Medicine, 2022)

Effectiveness of artificial intelligence screening in preventing vision loss from diabetes: a policy model. - Roomasa Channa; Risa M. Wolf; Michael D. Abràmoff; Harold P. Lehmann (npj Digit. Medicine, 2023)

Autonomous artificial intelligence for diabetic eye disease increases access and health equity in underserved populations. - Jane J. Huang; Roomasa Channa; Risa M. Wolf; Yiwen Dong 004; Mavis Liang; Jiangxia Wang; Michael D. Abràmoff; T. Y. Alvin Liu (npj Digit. Medicine, 2024)

Author Correction: Autonomous artificial intelligence for diabetic eye disease increases access and health equity in underserved populations. - Jane J. Huang; Roomasa Channa; Risa M. Wolf; Yiwen Dong 004; Mavis Liang; Jiangxia Wang; Michael D. Abràmoff; T. Y. Alvin Liu (npj Digit. Medicine, 2024)

Qualitative metrics from the biomedical literature for evaluating large language models in clinical decision-making: a narrative review. - Cindy N. Ho; Tiffany Tian; Alessandra T. Ayers; Rachel E. Aaron; Vidith Phillips; Risa M. Wolf; Nestoras Mathioudakis; Tinglong Dai; David C. Klonoff (BMC Medical Informatics Decis. Mak., 2024)

Cost-effectiveness of AI for pediatric diabetic eye exams from a health system perspective. - Mahnoor Ahmed; Tinglong Dai; Roomasa Channa; Michael D. Abràmoff; Harold P. Lehmann; Risa M. Wolf (npj Digit. Medicine, 2025)